AB InBev stock jumps 9% as earnings beat and beer volumes defy slump

AB InBev stock jumps 9% as earnings beat and beer volumes defy slump
Ananthu C U
05 May 2026, 18:17 PM

powered by

Invezz
AB InBev (BUD/ABI)

Buy AB InBev ADR (BUD). Earnings beat plus the first volume growth in three years signals the pricing-only model is shifting back toward real demand. The “balanced portfolio” (low/no-cal) and “beyond beer” (Cutwater) are growing fast, supporting margins and reducing reliance on legacy brands. Key thesis: volume inflects upward and growth mix keeps improving, letting the stock re-rate toward its fundamentals.

Key Risk: Volume growth fades again next quarter and management is forced back to relying mainly on price hikes to hit guidance.

Constellation Brands (STZ)

Buy STZ. If AB’s volume momentum is real, it lifts the whole beer/RTD category and validates consumer resilience—good for STZ’s beer exposure. Also, AB’s shift to low/no-cal and RTD increases category innovation, which tends to expand shelf space and overall demand where STZ has strong distribution and brand power. Key thesis: category strength + innovation cycle supports STZ earnings durability.

Key Risk: AB’s strength is mostly share gains at the expense of competitors, and STZ’s beer volumes/margins stall despite the sector bounce.

  • AB InBev beats estimates as shares jump on earnings, revenue growth.
  • Beer volumes rise 0.8%, marking first growth in three years.
  • No-alcohol segment grows fast, but demand risks still persist.

Shares of Anheuser-Busch InBev rose sharply on Tuesday after the world’s largest brewer reported first-quarter results that exceeded analyst expectations, supported by resilient beer demand and a return to volume growth.

American depositary receipts climbed 9.3%, building on gains earlier this year, after the company posted adjusted earnings per share of 97 cents, up from 81 cents a year earlier.

That figure topped analyst estimates of 89 cents per share.

Revenue came in at $15.27 billion, reflecting organic growth of 5.8% and also surpassing expectations of $14.8 billion.

A key highlight of the quarter was a return to volume growth, which has been elusive for the brewer in recent years.

Anheuser-Busch InBev reported a 0.8% organic increase in total volumes during the first three months of 2026, beating analyst expectations for a slight decline and marking the first increase in three years.

The company attributed the improvement to more favorable weather conditions and stable consumer sentiment.

“Cheers to beer — the strength of the category and the consistent execution of our consumer-centric strategy drove continued momentum across our footprint,” CEO Michel Doukeris said in a statement.

The volume growth comes despite broader challenges facing the alcohol industry.

In 2025, Anheuser-Busch InBev’s total sales volume declined 2.3%, with beer volumes falling 2.6%, as rising living costs and shifting consumer preferences weighed on demand.

Portfolio shift supports growth momentum

The brewer has increasingly relied on pricing and portfolio diversification to offset weakening consumption trends.

While price increases have driven much of its recent growth, the company is also expanding into faster-growing categories.

Its “balanced portfolio,” which includes low-carb, low-calorie, sugar-free, gluten-free, and no-alcohol beer offerings, recorded growth of 17%.

The company’s “beyond beer” segment, which includes ready-to-drink beverages such as Cutwater, posted a 37% increase in sales.

Particularly notable has been the performance of its no-alcohol beer segment.

The company reported that its alcohol-free portfolio delivered 34% revenue growth in 2025, with Corona Cero leading the expansion through strong double-digit volume gains.

In the first quarter of 2026, no-alcohol beer revenue rose a further 27%.

Anheuser-Busch InBev has been actively expanding this segment, rolling out alcohol-free versions of key brands such as Budweiser, Michelob Ultra, Corona, and Stella Artois, as it seeks to capture demand from health-conscious consumers.

Challenges persist despite strong quarter

Despite the upbeat results, structural challenges remain.

Global alcohol consumption continues to face headwinds from rising living costs, stricter immigration enforcement affecting social activity, and a shift toward healthier lifestyles.

The company’s flagship brands have also faced pressure.

Bud Light lost its long-standing dominance in the US market in 2023 following a marketing backlash, while competition from brands such as Modelo Especial and the rise of Michelob Ultra have reshaped the competitive landscape.

Although Michelob Ultra has gained traction due to its low-calorie positioning, investors remain cautious about whether its growth can fully offset declines in legacy brands.

Looking ahead, the company reiterated its expectation for full-year earnings before interest, taxes, depreciation, and amortization to grow between 4% and 8%.

Management also pointed to major upcoming global sporting events—including the Super Bowl, Winter Olympics, and FIFA World Cup—as potential catalysts for demand.